Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More This week, a team of scientists at Salesforce published a study detailing ...

Artificial intelligence has seen a huge surge of popularity in recent months, even years, and with programs like ChatGPT continuing to dominate headlines of the news cycle and other parts of life, A.I ...

Creates one of Australia's leading biotechnology companies Balanced portfolio of infectious disease and oncology assets with a Phase III HIV program Progen shareholders to have the option to ...

Rani and ProGen’s collaboration seeks to advance a GLP-1/GLP-2 dual agonist for the treatment of obesity. While GLP-1 agonists have been thoroughly discussed in recent years there are other less ...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (ROCE) ...

Progen Co., Ltd., a biotechnology company, engages in platform-based drug discovery and development activities. The company’s NTIG platform technology is used for the development of anti-cancer and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

April 16 (Reuters) - Australian biotech company Progen Pharmaceuticals Ltd. on Monday reported positive mid-stage clinical trial results for its liver cancer drug, sending its shares to an all-time ...